<p><strong>AVITA Medical</strong>（纳斯达克股票代码：RCEL）于 2026 年 2 月 12 日星期四下午 04:01 发布了第四季度财报。</p>
<p>以下是财报公告中的重要信息。</p>
<h3>财报</h3>
<p>AVITA Medical 的每股收益（EPS）超出预期 19.15%，报告的每股收益为$-0.38，而预估为$-0.47。</p>
<p>收入较去年同期下降了 79 万美元。</p>
<h3>过去财报分析</h3>
<p>上个季度该公司每股收益低于预期$0.02，随后股价在第二天上涨了 10.88%。</p>
<p>以下是 AVITA Medical 的历史表现：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th><strong>2025 年第三季度</strong></th>
<th><strong>2025 年第二季度</strong></th>
<th><strong>2025 年第一季度</strong></th>
<th><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>每股收益预估</strong></td>
<td>-0.44</td>
<td>-0.32</td>
<td>-0.51</td>
<td>-0.74</td>
</tr>
<tr>
<td><strong>每股收益实际</strong></td>
<td>-0.46</td>
<td>-0.38</td>
<td>-0.53</td>
<td>-0.44</td>
</tr>
<tr>
<td><strong>收入预估</strong></td>
<td>2770 万美元</td>
<td>3427 万美元</td>
<td>3279 万美元</td>
<td>3159 万美元</td>
</tr>
<tr>
<td><strong>收入实际</strong></td>
<td>1690 万美元</td>
<td>1842 万美元</td>
<td>1851 万美元</td>
<td>1841 万美元</td>
</tr>
</tbody>
</table>
<p>要跟踪 AVITA Medical 的所有财报发布，请 访问他们的财报日历。</p>
<p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>

RCEL

<p>AVITA Medical（纳斯达克代码：RCEL）于 2026 年 2 月 12 日公布了其第四季度财报，盈利超出预期 19.15%，每股收益为-0.38 美元，而预期为-0.47 美元。然而，收入较去年减少了 79 万美元。在前一个季度，公司每股收益未达到预期，差距为 0.02 美元，导致次日股价上涨 10.88%。历史表现显示，过去几个季度的每股收益和收入存在波动</p>

<p><strong>AVITA Medical</strong> (NASDAQ: RCEL) released its Q4 earnings on Thursday, February 12, 2026 at 04:01 PM.</p>
<div class="lb-trans"><p><strong>AVITA Medical</strong>（纳斯达克股票代码：RCEL）于 2026 年 2 月 12 日星期四下午 04:01 发布了第四季度财报。</p>
</div><p>Here's what's important from the earnings announcement.</p>
<div class="lb-trans"><p>以下是财报公告中的重要信息。</p>
</div><h3>Earnings</h3>
<div class="lb-trans"><h3>财报</h3>
</div><p>AVITA Medical beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.</p>
<div class="lb-trans"><p>AVITA Medical 的每股收益（EPS）超出预期 19.15%，报告的每股收益为$-0.38，而预估为$-0.47。</p>
</div><p>Revenue was down $790 thousand from the same period last year.</p>
<div class="lb-trans"><p>收入较去年同期下降了 79 万美元。</p>
</div><h3>Analysis of Past Earnings</h3>
<div class="lb-trans"><h3>过去财报分析</h3>
</div><p>Last quarter the company missed on EPS by $0.02 which was followed by a 10.88% increase in the share price the next day.</p>
<div class="lb-trans"><p>上个季度该公司每股收益低于预期$0.02，随后股价在第二天上涨了 10.88%。</p>
</div><p>Here's a look at AVITA Medical's past performance:</p>
<div class="lb-trans"><p>以下是 AVITA Medical 的历史表现：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.44</td>
<td>-0.32</td>
<td>-0.51</td>
<td>-0.74</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.46</td>
<td>-0.38</td>
<td>-0.53</td>
<td>-0.44</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>27.70M</td>
<td>34.27M</td>
<td>32.79M</td>
<td>31.59M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>16.90M</td>
<td>18.42M</td>
<td>18.51M</td>
<td>18.41M</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th><strong>2025 年第三季度</strong></th>
<th><strong>2025 年第二季度</strong></th>
<th><strong>2025 年第一季度</strong></th>
<th><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>每股收益预估</strong></td>
<td>-0.44</td>
<td>-0.32</td>
<td>-0.51</td>
<td>-0.74</td>
</tr>
<tr>
<td><strong>每股收益实际</strong></td>
<td>-0.46</td>
<td>-0.38</td>
<td>-0.53</td>
<td>-0.44</td>
</tr>
<tr>
<td><strong>收入预估</strong></td>
<td>2770 万美元</td>
<td>3427 万美元</td>
<td>3279 万美元</td>
<td>3159 万美元</td>
</tr>
<tr>
<td><strong>收入实际</strong></td>
<td>1690 万美元</td>
<td>1842 万美元</td>
<td>1851 万美元</td>
<td>1841 万美元</td>
</tr>
</tbody>
</table>
</div><p>To track all earnings releases for AVITA Medical visit their earnings calendar here.</p>
<div class="lb-trans"><p>要跟踪 AVITA Medical 的所有财报发布，请 访问他们的财报日历。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>
</div>

AVITA Medical 第四季度财报总结及主要内容